Difficulties and countermeasures for the international acceptance of clinical trial data in China
SUN Yi-bu
HAO Zi-ruo
CHEN Yu-wen
Abstract：The authenticity and validity of clinical trial data are paramount in drug development.In the past years,the international acceptance of clinical trial date from China has been limited,making it a critical yet challenging endeavor to enhance their global recognition.This paper introduces the evolution of China's clinical trial system,summarizes and analyzes the current challenges and obstacles hindering the international acceptance of its clinical trial data,and offers suggestions for future development.
Keywords：clinical trialdatamulti-center clinical studyoverseas clinical trial
Publication Date：2025-12-15
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：4( 2486-2489 )